Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-039926
Filing Date
2020-02-18
Accepted
2020-02-18 11:43:32
Documents
2
Period of Report
2020-02-18

Document Format Files

Seq Description Document Type Size
1 6-K d891073d6k.htm 6-K 9054
2 EX-99.1 d891073dex991.htm EX-99.1 90573
  Complete submission text file 0001193125-20-039926.txt   100650
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 20624142
SIC: 2834 Pharmaceutical Preparations